Felcia Lai

606 total citations
22 papers, 451 citations indexed

About

Felcia Lai is a scholar working on Pharmacology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Felcia Lai has authored 22 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 6 papers in Molecular Biology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Felcia Lai's work include Cannabis and Cannabinoid Research (7 papers), Crystallography and molecular interactions (5 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). Felcia Lai is often cited by papers focused on Cannabis and Cannabinoid Research (7 papers), Crystallography and molecular interactions (5 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). Felcia Lai collaborates with scholars based in Australia, United States and United Kingdom. Felcia Lai's co-authors include David E. Hibbs, Paul W. Groundwater, Bryson A. Hawkins, Jonathan J. Du, Yiqun Chang, Peter A. Williams, Linda Váradi, Senem Akkoç, İlhan Özer İlhan and Yetkın Gök and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Physical Chemistry Chemical Physics and The Journal of Physical Chemistry A.

In The Last Decade

Felcia Lai

21 papers receiving 444 citations

Peers

Countries citing papers authored by Felcia Lai

Since Specialization

Citations

This map shows the geographic impact of Felcia Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felcia Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felcia Lai more than expected).

Fields of papers citing papers by Felcia Lai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Felcia Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felcia Lai. The network helps show where Felcia Lai may publish in the future.

Co-authorship network of co-authors of Felcia Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Felcia Lai. A scholar is included among the top collaborators of Felcia Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felcia Lai. Felcia Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Alkylation-based optimization of antifungal FPPS inhibitors yields a potent, broad-spectrum lipophilic zoledronate derivative 2025 ·mBio ·(unknown), Felcia Lai, (unknown), (unknown), Leona T. Campbell, (unknown), David E. Hibbs, Jane R. Hanrahan, (unknown)	0
2	An experimental and theoretical charge density study of theophylline and malonic acid cocrystallization 2022 ·RSC Advances ·Bryson A. Hawkins, Jonathan J. Du, Felcia Lai, (unknown), Peter A. Williams, Paul W. Groundwater, James A. Platts, Jacob Overgaard, David E. Hibbs	7
3	Exploring the excited-state charge transfer fluorescence profile of 7-hydroxycoumarin and 2-methylimidazole – a combined X-ray diffraction and theoretical approach 2022 ·Physical Chemistry Chemical Physics ·Bryson A. Hawkins, (unknown), Jonathan J. Du, Felcia Lai, James A. Platts, Paul W. Groundwater, David E. Hibbs	3
4	Comprehensive Characterization of a Systematic Library of Alkyl and Alicyclic Synthetic Cannabinoids Related to CUMYL-PICA, CUMYL-BUTICA, CUMYL-CBMICA, and CUMYL-PINACA 2022 ·ACS Chemical Neuroscience ·(unknown), (unknown), (unknown), Rochelle Boyd, Felcia Lai, (unknown), (unknown), Roy Gerona, Matthew Connolly, Huiling Liu, David E. Hibbs, Elizabeth A. Cairns, Samuel D. Banister, Christophe P. Stove	6
5	The role of adjuvants in overcoming antibacterial resistance due to enzymatic drug modification 2022 ·RSC Medicinal Chemistry ·(unknown), (unknown), (unknown), Felcia Lai, Bryson A. Hawkins, Jonathan J. Du, Eric J. Sundberg, Nicolas Sluis‐Cremer, David E. Hibbs, Paul W. Groundwater	12
6	A Guide to In Silico Drug Design 2022 ·Pharmaceutics ·Yiqun Chang, Bryson A. Hawkins, Jonathan J. Du, Paul W. Groundwater, David E. Hibbs, Felcia Lai	122
7	Synthesis and pharmacological evaluation of newly detected synthetic cannabinoid receptor agonists AB-4CN-BUTICA, MMB-4CN-BUTINACA, MDMB-4F-BUTICA, MDMB-4F-BUTINACA and their analogs 2022 ·Frontiers in Psychiatry ·(unknown), Rochelle Boyd, Shuli Chen, (unknown), Jia Lin Luo, (unknown), (unknown), (unknown), (unknown), Iain S. McGregor, Marina Santiago, Felcia Lai, Roy Gerona, Mark Connor, David E. Hibbs, Elizabeth A. Cairns, Michelle Glass, (unknown), Samuel D. Banister	8
8	Putative Synthetic Cannabinoids MEPIRAPIM, 5F-BEPIRAPIM (NNL-2), and Their Analogues Are T-Type Calcium Channel (Ca_V3) Inhibitors 2022 ·ACS Chemical Neuroscience ·Richard C. Kevin, (unknown), (unknown), Rochelle Boyd, Elizabeth A. Cairns, (unknown), Felcia Lai, Jia Lin Luo, (unknown), (unknown), Roy Gerona, David E. Hibbs, Iain S. McGregor, Michelle Glass, Mark Connor, Chris Bladen, Gerald W. Zamponi, Samuel D. Banister	4
9	Understanding Hygroscopicity of Theophyllineviaa Novel Cocrystal Polymorph: A Charge Density Study 2021 ·The Journal of Physical Chemistry A ·(unknown), Jonathan J. Du, Felcia Lai, (unknown), Bryson A. Hawkins, Jennifer Ong, Paul W. Groundwater, James A. Platts, David E. Hibbs	11
10	Analyzing Hydration Differences in Cocrystal Polymorphs: High-Resolution X-ray Investigation of Caffeine–Glutaric Acid Cocrystals 2021 ·Crystal Growth & Design ·Bryson A. Hawkins, (unknown), Jonathan J. Du, Felcia Lai, (unknown), (unknown), Paul W. Groundwater, James A. Platts, David E. Hibbs	8
11	NNL-3: A Synthetic Intermediate or a New Class of Hydroxybenzotriazole Esters with Cannabinoid Receptor Activity? 2021 ·ACS Chemical Neuroscience ·(unknown), Elizabeth A. Cairns, Katharina Elisabeth Grafinger, Annelies Cannaert, (unknown), Shuli Chen, (unknown), (unknown), Felcia Lai, (unknown), Roy Gerona, (unknown), Richard C. Kevin, Iain S. McGregor, David E. Hibbs, Michelle Glass, Christophe P. Stove, Volker Auwärter, Samuel D. Banister	8
12	Structure–activity relationships of valine, tert-leucine, and phenylalanine amino acid-derived synthetic cannabinoid receptor agonists related to ADB-BUTINACA, APP-BUTINACA, and ADB-P7AICA 2021 ·RSC Medicinal Chemistry ·(unknown), Elizabeth A. Cairns, Richard C. Kevin, Felcia Lai, Katharina Elisabeth Grafinger, Shuli Chen, (unknown), (unknown), Rochelle Boyd, Lewis Martin, Iain S. McGregor, Roy Gerona, David E. Hibbs, Volker Auwärter, Michelle Glass, Christophe P. Stove, Samuel D. Banister	21
13	Ceramide Regulates Anti-Tumor Mechanisms of Erianin in Androgen-Sensitive and Castration-Resistant Prostate Cancers 2021 ·Frontiers in Oncology ·(unknown), (unknown), (unknown), Felcia Lai, Chanlu Xie, Yang Zhao, Shaohui Cui, Jinbiao Chen, Collin Tran, Qian Wang, Shubiao Zhang, Anthony S. Don, George Li, Jane R. Hanrahan, Yanfei Qi	14
14	Strategies to develop selective CB2 receptor agonists from indole carboxamide synthetic cannabinoids 2019 ·European Journal of Medicinal Chemistry ·Michael Moir, (unknown), Felcia Lai, Mark Connor, David E. Hibbs, Michael Kassiou	23
15	cyp51A Mutations, Extrolite Profiles, and Antifungal Susceptibility in Clinical and Environmental Isolates of the Aspergillus viridinutans Species Complex 2019 ·Antimicrobial Agents and Chemotherapy ·Jessica Talbot, Jens C. Frisvad, Jacques F. Meis, Ferry Hagen, Paul E. Verweij, David E. Hibbs, Felcia Lai, Paul W. Groundwater, Robert A. Samson, Sarah Kidd, Vanessa R. Barrs, Jos Houbraken	20
16	Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates 2018 ·Journal of Antimicrobial Chemotherapy ·Jessica Talbot, (unknown), Catriona Halliday, David E. Hibbs, Felcia Lai, Francisco J. López-Ruiz, (unknown), Robert Park, William S. Cuddy, Chayanika Biswas, Louise Cooley, Dee Carter, Tania C. Sorrell, Vanessa R. Barrs, Sharon C.-A. Chen	33
17	Monoclinic Paracetamol vs. Paracetamol-4,4′-Bipyridine Co-Crystal; What Is the Difference? A Charge Density Study 2018 ·Crystals ·Jonathan J. Du, Felcia Lai, Linda Váradi, Peter A. Williams, Paul W. Groundwater, James A. Platts, David E. Hibbs, Jacob Overgaard	7
18	New Delhi Metallo-β-Lactamase-1: Structure, Inhibitors and Detection of Producers 2016 ·Future Medicinal Chemistry ·Paul W. Groundwater, (unknown), Felcia Lai, Linda Váradi, Jinlong Tan, John D. Perry, David E. Hibbs	43
19	A comparison of the experimental and theoretical charge density distributions in two polymorphic modifications of piroxicam 2016 ·Physical Chemistry Chemical Physics ·Felcia Lai, Jonathan J. Du, Peter A. Williams, Linda Váradi, (unknown), Paul W. Groundwater, Jacob Overgaard, James A. Platts, David E. Hibbs	16
20	Identification of dual PPARα/γ agonists and their effects on lipid metabolism 2015 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), Linda Váradi, Rose Cairns, (unknown), Vivian W. Y. Liao, Peta Wood, Seher Balaban, Jennifer Ong, (unknown), Felcia Lai, Andrew J. Hoy, Thomas Grewal, Paul W. Groundwater, David E. Hibbs	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact